Abstract
Nephrology and Hypertension; Cincinnati Children’s Hospital Medical Center; University of Cincinnati College of Medicine; Cincinnati, OH Studies cited in this editorial that were performed in the author’s laboratory were supported by grants from the NIH (R01 DK53289, RO1 DK069749, and R21 DK070163). Abbott Diagnostics has signed an exclusive licensing agreement with Cincinnati Children’s Hospital for developing urine NGAL as a biomarker of acute renal failure.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
